{"id":150825,"date":"2020-08-08T22:24:13","date_gmt":"2020-08-08T22:24:13","guid":{"rendered":"https:\/\/www.bnreport.com\/small-cap-movers-redx-pharma-joins-junior-biotech-success-stories\/"},"modified":"2020-08-08T22:24:13","modified_gmt":"2020-08-08T22:24:13","slug":"small-cap-movers-redx-pharma-joins-junior-biotech-success-stories","status":"publish","type":"post","link":"https:\/\/www.bnreport.com\/en\/small-cap-movers-redx-pharma-joins-junior-biotech-success-stories\/","title":{"rendered":"Small Cap Movers: Redx Pharma joins junior biotech success stories"},"content":{"rendered":"<p>Redx Pharma PLC (LON:REDX) joined the recent spate of junior biotech success stories with an 80% jump to 45p this week on the back of a licencing deal with <a href=\"https:\/\/www.proactiveinvestors.co.uk\/LON:AZN\/AstraZeneca\/\" rel=\"noreferrer noopener\" target=\"_blank\">AstraZeneca<\/a>.<\/p>\n<p>The FTSE 100 giant will pay US$17mln to develop Redxs RXC006 for idiopathic pulmonary fibrosis, where progressive scarring of the lungs is usually fatal.<\/p>\n<p>If it makes it to market, Redx will receive up to a further US$360mln in milestones plus royalties.<\/p>\n<p>Thats quite an achievement for a junior player that, until Monday, was valued at \u00a348mln and is now worth just shy of \u00a388mln \u2013 up over 200% since lockdown started.<\/p>\n<p>The change of fortunes is all the more remarkable given its brief spell in administration three years ago and some struggles in raising funds.<\/p>\n<p>Experts say coronavirus (COVID-19) patients can develop lung fibrosis, so perhaps the pandemic has accelerated the markets interest in this condition.<\/p>\n<p>Many sector-mates have seen their value rocket on the back of projects related to the pandemic: <a href=\"https:\/\/www.proactiveinvestors.co.uk\/LON:GDR\/Genedrive-PLC\/\" rel=\"noreferrer noopener\" target=\"_blank\">Genedrive PLC<\/a> (<a href=\"https:\/\/www.proactiveinvestors.co.uk\/LON:GDR\/Genedrive-PLC\/\" rel=\"noreferrer noopener\" target=\"_blank\">LON:GDR<\/a>), <a href=\"https:\/\/www.proactiveinvestors.co.uk\/LON:AVCT\/Avacta-Group-PLC\/\" rel=\"noreferrer noopener\" target=\"_blank\">Avacta Group PLC<\/a> (<a href=\"https:\/\/www.proactiveinvestors.co.uk\/LON:AVCT\/Avacta-Group-PLC\/\" rel=\"noreferrer noopener\" target=\"_blank\">LON:AVCT<\/a>) and <a href=\"https:\/\/www.proactiveinvestors.co.uk\/LON:ODX\/Omega-Diagnostics-Group-PLC\/\" rel=\"noreferrer noopener\" target=\"_blank\">Omega Diagnostics Group PLC<\/a> (<a href=\"https:\/\/www.proactiveinvestors.co.uk\/LON:ODX\/Omega-Diagnostics-Group-PLC\/\" rel=\"noreferrer noopener\" target=\"_blank\">LON:ODX<\/a>) have soared 860%, 760% and 580% respectively with their tests. <a href=\"https:\/\/www.proactiveinvestors.co.uk\/LON:TILS\/Tiziana-Life-Sciences-PLC\/\" rel=\"noreferrer noopener\" target=\"_blank\">Tiziana Life Sciences PLC<\/a> (<a href=\"https:\/\/www.proactiveinvestors.co.uk\/LON:TILS\/Tiziana-Life-Sciences-PLC\/\" rel=\"noreferrer noopener\" target=\"_blank\">LON:TILS<\/a>) grew four-fold after developing a treatment candidate.<\/p>\n<p>Genedrive advanced a further 16% to 87p this week after teaming up with US life sciences firm Beckman Coulter to fully automate the entire laboratory testing process for COVID-19 samples.<\/p>\n<p>It was a rollercoaster week for reach4entertainment enterprises PLC (<a href=\"https:\/\/www.proactiveinvestors.co.uk\/LON:R4E\/reach4entertainment-\/\" rel=\"noreferrer noopener\" target=\"_blank\">LON:R4E<\/a>), which crashed by over 50% on Tuesday after unveiling plans to delist from AIM to cut spending, following a big hit to trading while theatres and concert venues remain closed.<\/p>\n<p>But the advertiser swiftly recovered 145% by Friday after chief executive Marc Boyan upped his stake to 16.06%, while Sigmund Freuds great-grandson, Matthew, also seemingly increased his holding to 14.95%. Herald Investment, instead, offloaded its 14.42% stake. The stock ended the week 43% higher at 0.3p.<\/p>\n<p>Turning to the wider market, the AIM All-Share was up a solid 4.5% to 924, outperforming the FTSE 100 index&#039;s 2% ascent to 6,018.<\/p>\n<p>It seems anomalous Feedback doesnt already have a massive fan club. While shares rocketed last week after its imaging-based communication platform, Bleepa, was awarded a place on the NHSx National Clinical Communication Tool framework, they have since tracked back to 1.2p. Buying interest may have been stifled by a big seller, who is now out of the market, according to the bandits on the bulletin boards. If this is the case, then watch this space.<\/p>\n<p>Among the risers, wound care and medical devices specialist <a href=\"https:\/\/www.proactiveinvestors.co.uk\/LON:SCPA\/Scapa-Group-PLC\/\" rel=\"noreferrer noopener\" target=\"_blank\">Scapa Group PLC<\/a> (<a href=\"https:\/\/www.proactiveinvestors.co.uk\/LON:SCPA\/Scapa-Group-PLC\/\" rel=\"noreferrer noopener\" target=\"_blank\">LON:SCPA<\/a>) soared 41% to 120p after revealing profits are currently 10% ahead of expectations, thanks to a swift reaction to the coronavirus disruption.<\/p>\n<p>Cleantech tiddler <a href=\"https:\/\/www.proactiveinvestors.co.uk\/LON:VDTK\/Verditek\/\" rel=\"noreferrer noopener\" target=\"_blank\">Verditek<\/a> PLC (<a href=\"https:\/\/www.proactiveinvestors.co.uk\/LON:VDTK\/Verditek\/\" rel=\"noreferrer noopener\" target=\"_blank\">LON:VDTK<\/a>) shot up 34% to 15p after receiving a follow-on order worth US$2.2mln from Pakistan&#039;s SAF Group for six containerised ultra-lightweight solar panels.<\/p>\n<p>Elsewhere, virtual reality entertainment specialist <a href=\"https:\/\/www.proactiveinvestors.co.uk\/LON:IMMO\/Immotion-Group\/\" rel=\"noreferrer noopener\" target=\"_blank\">Immotion Group<\/a> PLC (<a href=\"https:\/\/www.proactiveinvestors.co.uk\/LON:IMMO\/Immotion-Group\/\" rel=\"noreferrer noopener\" target=\"_blank\">LON:IMMO<\/a>) climbed 24% to 3p after launching a range of ultra-violet anti-bacterial cleaning cabinets, initially designed for its own headsets but later expanded to third parties following several commercial enquiries. It also opened its flagship &#039;Ocean Explorer&#039; immersive centre at Mandalay Bay Resort and Casino in Las Vegas.<\/p>\n<p>Franco Manca and The Real Greek restaurants&#039; owner The Fulham Shore PLC (<a href=\"https:\/\/www.proactiveinvestors.co.uk\/LON:FUL\/Fulham-Shore-PLC\/\" rel=\"noreferrer noopener\" target=\"_blank\">LON:F<\/a><a href=\"https:\/\/www.proactiveinvestors.co.uk\/companies\/news\/926126\/small-cap-movers-redx-pharma-joins-junior-biotech-success-stories-926126.html\" rel=\"noreferrer noopener\" target=\"_blank\">Read More \u2013 Source<\/a><br \/>\n[contf]<br \/>\n[contfnew]<br \/>\n        <img decoding=\"async\" src=\"https:\/\/webfiles.thecse.com\/PRO_LOGO_P_COLOUR.png?sYToe11NLbcXiyGkVa5syF9WB04cy98G\"\/><\/p>\n<h5><a href=\"https:\/\/www.proactiveinvestors.co.uk\/\" rel=\"noreferrer noopener\" target=\"_blank\">Proactiveinvestors<\/a><\/h5>\n<p>[contfnewc]<br \/>\n[contfnewc]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Redx Pharma PLC (LON:REDX) joined the recent spate of junior biotech success stories with an 80% jum..<\/p>\n","protected":false},"author":1,"featured_media":150826,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[46],"tags":[],"class_list":["post-150825","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-politics"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Small Cap Movers: Redx Pharma joins junior biotech success stories - Business News Report<\/title>\n<meta name=\"description\" content=\"Redx Pharma PLC (LON:REDX) joined the recent spate of junior biotech success stories with an 80% jum..\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.bnreport.com\/en\/small-cap-movers-redx-pharma-joins-junior-biotech-success-stories\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Small Cap Movers: Redx Pharma joins junior biotech success stories - Business News Report\" \/>\n<meta property=\"og:description\" content=\"Redx Pharma PLC (LON:REDX) joined the recent spate of junior biotech success stories with an 80% jum..\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.bnreport.com\/en\/small-cap-movers-redx-pharma-joins-junior-biotech-success-stories\/\" \/>\n<meta property=\"og:site_name\" content=\"Business News Report\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Business-NewsReport-328225811095934\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-08-08T22:24:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.bnreport.com\/wp-content\/uploads\/2020\/08\/1200z630_1596799339_2019-12-03-09-14-24_e8c4626fad3832268ef743c3de975b24.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"infopal11\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@BNReport\" \/>\n<meta name=\"twitter:site\" content=\"@BNReport\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"infopal11\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/small-cap-movers-redx-pharma-joins-junior-biotech-success-stories\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/small-cap-movers-redx-pharma-joins-junior-biotech-success-stories\\\/\"},\"author\":{\"name\":\"infopal11\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#\\\/schema\\\/person\\\/19d1c5a2dd7f60584a09de4a7805d68f\"},\"headline\":\"Small Cap Movers: Redx Pharma joins junior biotech success stories\",\"datePublished\":\"2020-08-08T22:24:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/small-cap-movers-redx-pharma-joins-junior-biotech-success-stories\\\/\"},\"wordCount\":556,\"publisher\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/small-cap-movers-redx-pharma-joins-junior-biotech-success-stories\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.bnreport.com\\\/wp-content\\\/uploads\\\/2020\\\/08\\\/1200z630_1596799339_2019-12-03-09-14-24_e8c4626fad3832268ef743c3de975b24.jpg\",\"articleSection\":[\"Politics\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/small-cap-movers-redx-pharma-joins-junior-biotech-success-stories\\\/\",\"url\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/small-cap-movers-redx-pharma-joins-junior-biotech-success-stories\\\/\",\"name\":\"Small Cap Movers: Redx Pharma joins junior biotech success stories - Business News Report\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/small-cap-movers-redx-pharma-joins-junior-biotech-success-stories\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/small-cap-movers-redx-pharma-joins-junior-biotech-success-stories\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.bnreport.com\\\/wp-content\\\/uploads\\\/2020\\\/08\\\/1200z630_1596799339_2019-12-03-09-14-24_e8c4626fad3832268ef743c3de975b24.jpg\",\"datePublished\":\"2020-08-08T22:24:13+00:00\",\"description\":\"Redx Pharma PLC (LON:REDX) joined the recent spate of junior biotech success stories with an 80% jum..\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/small-cap-movers-redx-pharma-joins-junior-biotech-success-stories\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.bnreport.com\\\/en\\\/small-cap-movers-redx-pharma-joins-junior-biotech-success-stories\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/small-cap-movers-redx-pharma-joins-junior-biotech-success-stories\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.bnreport.com\\\/wp-content\\\/uploads\\\/2020\\\/08\\\/1200z630_1596799339_2019-12-03-09-14-24_e8c4626fad3832268ef743c3de975b24.jpg\",\"contentUrl\":\"https:\\\/\\\/www.bnreport.com\\\/wp-content\\\/uploads\\\/2020\\\/08\\\/1200z630_1596799339_2019-12-03-09-14-24_e8c4626fad3832268ef743c3de975b24.jpg\",\"width\":1200,\"height\":630},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/small-cap-movers-redx-pharma-joins-junior-biotech-success-stories\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u0627\u0644\u0631\u0626\u064a\u0633\u064a\u0629\",\"item\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Small Cap Movers: Redx Pharma joins junior biotech success stories\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/\",\"name\":\"Business News Report\",\"description\":\"Latest News on the World of Politics &amp; Business\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#organization\",\"name\":\"\u0628\u0632\u0646\u0633 \u0631\u064a\u0628\u0648\u0631\u062a \u0627\u0644\u0627\u062e\u0628\u0627\u0631\u064a\",\"url\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.bnreport.com\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/LOGO2.png\",\"contentUrl\":\"https:\\\/\\\/www.bnreport.com\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/LOGO2.png\",\"width\":200,\"height\":50,\"caption\":\"\u0628\u0632\u0646\u0633 \u0631\u064a\u0628\u0648\u0631\u062a \u0627\u0644\u0627\u062e\u0628\u0627\u0631\u064a\"},\"image\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/Business-NewsReport-328225811095934\\\/\",\"https:\\\/\\\/x.com\\\/BNReport\",\"https:\\\/\\\/www.instagram.com\\\/business.newsreport\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#\\\/schema\\\/person\\\/19d1c5a2dd7f60584a09de4a7805d68f\",\"name\":\"infopal11\",\"url\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/author\\\/infopal11\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Small Cap Movers: Redx Pharma joins junior biotech success stories - Business News Report","description":"Redx Pharma PLC (LON:REDX) joined the recent spate of junior biotech success stories with an 80% jum..","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.bnreport.com\/en\/small-cap-movers-redx-pharma-joins-junior-biotech-success-stories\/","og_locale":"en_US","og_type":"article","og_title":"Small Cap Movers: Redx Pharma joins junior biotech success stories - Business News Report","og_description":"Redx Pharma PLC (LON:REDX) joined the recent spate of junior biotech success stories with an 80% jum..","og_url":"https:\/\/www.bnreport.com\/en\/small-cap-movers-redx-pharma-joins-junior-biotech-success-stories\/","og_site_name":"Business News Report","article_publisher":"https:\/\/www.facebook.com\/Business-NewsReport-328225811095934\/","article_published_time":"2020-08-08T22:24:13+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2020\/08\/1200z630_1596799339_2019-12-03-09-14-24_e8c4626fad3832268ef743c3de975b24.jpg","type":"image\/jpeg"}],"author":"infopal11","twitter_card":"summary_large_image","twitter_creator":"@BNReport","twitter_site":"@BNReport","twitter_misc":{"Written by":"infopal11","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.bnreport.com\/en\/small-cap-movers-redx-pharma-joins-junior-biotech-success-stories\/#article","isPartOf":{"@id":"https:\/\/www.bnreport.com\/en\/small-cap-movers-redx-pharma-joins-junior-biotech-success-stories\/"},"author":{"name":"infopal11","@id":"https:\/\/www.bnreport.com\/en\/#\/schema\/person\/19d1c5a2dd7f60584a09de4a7805d68f"},"headline":"Small Cap Movers: Redx Pharma joins junior biotech success stories","datePublished":"2020-08-08T22:24:13+00:00","mainEntityOfPage":{"@id":"https:\/\/www.bnreport.com\/en\/small-cap-movers-redx-pharma-joins-junior-biotech-success-stories\/"},"wordCount":556,"publisher":{"@id":"https:\/\/www.bnreport.com\/en\/#organization"},"image":{"@id":"https:\/\/www.bnreport.com\/en\/small-cap-movers-redx-pharma-joins-junior-biotech-success-stories\/#primaryimage"},"thumbnailUrl":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2020\/08\/1200z630_1596799339_2019-12-03-09-14-24_e8c4626fad3832268ef743c3de975b24.jpg","articleSection":["Politics"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.bnreport.com\/en\/small-cap-movers-redx-pharma-joins-junior-biotech-success-stories\/","url":"https:\/\/www.bnreport.com\/en\/small-cap-movers-redx-pharma-joins-junior-biotech-success-stories\/","name":"Small Cap Movers: Redx Pharma joins junior biotech success stories - Business News Report","isPartOf":{"@id":"https:\/\/www.bnreport.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.bnreport.com\/en\/small-cap-movers-redx-pharma-joins-junior-biotech-success-stories\/#primaryimage"},"image":{"@id":"https:\/\/www.bnreport.com\/en\/small-cap-movers-redx-pharma-joins-junior-biotech-success-stories\/#primaryimage"},"thumbnailUrl":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2020\/08\/1200z630_1596799339_2019-12-03-09-14-24_e8c4626fad3832268ef743c3de975b24.jpg","datePublished":"2020-08-08T22:24:13+00:00","description":"Redx Pharma PLC (LON:REDX) joined the recent spate of junior biotech success stories with an 80% jum..","breadcrumb":{"@id":"https:\/\/www.bnreport.com\/en\/small-cap-movers-redx-pharma-joins-junior-biotech-success-stories\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.bnreport.com\/en\/small-cap-movers-redx-pharma-joins-junior-biotech-success-stories\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.bnreport.com\/en\/small-cap-movers-redx-pharma-joins-junior-biotech-success-stories\/#primaryimage","url":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2020\/08\/1200z630_1596799339_2019-12-03-09-14-24_e8c4626fad3832268ef743c3de975b24.jpg","contentUrl":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2020\/08\/1200z630_1596799339_2019-12-03-09-14-24_e8c4626fad3832268ef743c3de975b24.jpg","width":1200,"height":630},{"@type":"BreadcrumbList","@id":"https:\/\/www.bnreport.com\/en\/small-cap-movers-redx-pharma-joins-junior-biotech-success-stories\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u0627\u0644\u0631\u0626\u064a\u0633\u064a\u0629","item":"https:\/\/www.bnreport.com\/en\/"},{"@type":"ListItem","position":2,"name":"Small Cap Movers: Redx Pharma joins junior biotech success stories"}]},{"@type":"WebSite","@id":"https:\/\/www.bnreport.com\/en\/#website","url":"https:\/\/www.bnreport.com\/en\/","name":"Business News Report","description":"Latest News on the World of Politics &amp; Business","publisher":{"@id":"https:\/\/www.bnreport.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.bnreport.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.bnreport.com\/en\/#organization","name":"\u0628\u0632\u0646\u0633 \u0631\u064a\u0628\u0648\u0631\u062a \u0627\u0644\u0627\u062e\u0628\u0627\u0631\u064a","url":"https:\/\/www.bnreport.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.bnreport.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2020\/12\/LOGO2.png","contentUrl":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2020\/12\/LOGO2.png","width":200,"height":50,"caption":"\u0628\u0632\u0646\u0633 \u0631\u064a\u0628\u0648\u0631\u062a \u0627\u0644\u0627\u062e\u0628\u0627\u0631\u064a"},"image":{"@id":"https:\/\/www.bnreport.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Business-NewsReport-328225811095934\/","https:\/\/x.com\/BNReport","https:\/\/www.instagram.com\/business.newsreport"]},{"@type":"Person","@id":"https:\/\/www.bnreport.com\/en\/#\/schema\/person\/19d1c5a2dd7f60584a09de4a7805d68f","name":"infopal11","url":"https:\/\/www.bnreport.com\/en\/author\/infopal11\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/posts\/150825","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/comments?post=150825"}],"version-history":[{"count":0,"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/posts\/150825\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/media\/150826"}],"wp:attachment":[{"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/media?parent=150825"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/categories?post=150825"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/tags?post=150825"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}